{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T22:54:12Z","timestamp":1788648852228,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","surveyophthalmol.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Survey of Ophthalmology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.survophthal.2024.05.006","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T15:58:56Z","timestamp":1716307136000},"page":"733-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical features of ocular damage in systemic lupus erythematosus and risk factors for hydroxychloroquine-related complications"],"prefix":"10.1016","volume":"69","author":[{"given":"Tiantian","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.survophthal.2024.05.006_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s43162-021-00047-y","article-title":"Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus","volume":"33","author":"Abdelbaky","year":"2021","journal-title":"Egypt J Intern Med"},{"key":"10.1016\/j.survophthal.2024.05.006_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ajo.2018.08.013","article-title":"Evaluation of retromode imaging for use in hydroxychloroquine retinopathy","volume":"196","author":"Ahn","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.006_bib3","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"7454","key":"10.1016\/j.survophthal.2024.05.006_bib4","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.006_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41927-021-00203-5","article-title":"Retinopathy in newly-diagnosed systemic lupus erythematosus: should we screen for ocular involvement?","volume":"5","author":"Bashiri","year":"2021","journal-title":"BMC Rheumatol."},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.006_bib6","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10067-013-2214-6","article-title":"Analysis of the prevalence of cataracts and glaucoma in systemic lupus erythematosus and evaluation of the rheumatologists' practice for the monitoring of glucocorticoid eye toxicity","volume":"32","author":"Carli","year":"2013","journal-title":"Clin Rheumatol."},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/0961203320903080","article-title":"Ocular involvement in systemic lupus erythematosus patients: a paradigm shift based on the experience of a tertiary referral center","volume":"29","author":"Dias-Santos","year":"2020","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.006_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/09273948.2016.1212078","article-title":"Ophthalmic manifestations in chronic inflammatory rheumatic diseases at a referral hospital of Yaounde, Cameroon","volume":"26","author":"Domngang Noche","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"issue":"7109","key":"10.1016\/j.survophthal.2024.05.006_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Bmj"},{"issue":"Suppl 1","key":"10.1016\/j.survophthal.2024.05.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00393-020-00785-4","article-title":"Safety management in treatment with antimalarials in rheumatology. Interdisciplinary recommendations on the basis of a systematic literature review","volume":"80","author":"Fiehn","year":"2021","journal-title":"Z Rheumatol."},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.006_bib11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1136\/bjophthalmol-2018-313679","article-title":"Swept source optical coherence tomography angiography in patients treated with hydroxychloroquine: correlation with morphological and functional tests","volume":"105","author":"Forte","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.survophthal.2024.05.006_bib12","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","article-title":"Use of the GRADE approach in systematic reviews and guidelines","volume":"123","author":"Granholm","year":"2019","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.006_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/antib5020012","article-title":"\u03b2(2)GP1, Anti-\u03b2(2)GP1 antibodies and platelets: key players in the antiphospholipid syndrome.","volume":"5","author":"Ho","year":"2016","journal-title":"Antibodies"},{"key":"10.1016\/j.survophthal.2024.05.006_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.comppsych.2015.05.001","article-title":"Prevalence of suicide attempts among Chinese adolescents: a meta-analysis of cross-sectional studies","volume":"61","author":"Hu","year":"2015","journal-title":"Compr Psychiatry"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.006_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13075-018-1634-8","article-title":"Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines","volume":"20","author":"Jorge","year":"2018","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10067-016-3534-0","article-title":"Uveitis in childhood-onset systemic lupus erythematosus patients: a multicenter survey","volume":"36","author":"Kahwage","year":"2017","journal-title":"Clin Rheumatol."},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.006_bib17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12348-016-0081-4","article-title":"Role of lupus retinopathy in systemic lupus erythematosus","volume":"6","author":"Kharel Sitaula","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"9","key":"10.1016\/j.survophthal.2024.05.006_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.survophthal.2024.05.006_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/ICU.0000000000000810","article-title":"Update on ophthalmic manifestations of systemic lupus erythematosus: pathogenesis and precision medicine","volume":"32","author":"Lee","year":"2021","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.006_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/acr2.11531","article-title":"Systemic lupus erythematosus may be a risk factor for antimalarial-induced retinopathy compared with other rheumatologic diseases","volume":"5","author":"Liu","year":"2023","journal-title":"ACR Open Rheumatol."},{"issue":"20","key":"10.1016\/j.survophthal.2024.05.006_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012264","article-title":"Understanding ocular findings and manifestations of systemic lupus erythematosus: update review of the literature","volume":"23","author":"Lubo\u0144","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.006_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/07853899709113704","article-title":"The clinical significance of antiphospholipid antibodies","volume":"29","author":"Martini","year":"1997","journal-title":"Ann Med"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/ard.55.3.187","article-title":"Retinal toxicity in long term hydroxychloroquine treatment","volume":"55","author":"Mavrikakis","year":"1996","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.006_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med"},{"issue":"7","key":"10.1016\/j.survophthal.2024.05.006_bib25","doi-asserted-by":"crossref","first-page":"e517","DOI":"10.1016\/S2665-9913(21)00009-6","article-title":"The Asia-Pacific league of associations for rheumatology consensus statements on the management of systemic lupus erythematosus","volume":"3","author":"Mok","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.survophthal.2024.05.006_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2147\/OARRR.S167783","article-title":"Sj\u00f6gren's syndrome and systemic lupus erythematosus: links and risks","volume":"11","author":"Pasoto","year":"2019","journal-title":"Open Access Rheumatol."},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/art.41121","article-title":"Hydroxychloroquine blood levels predict hydroxychloroquine retinopathy","volume":"72","author":"Petri","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"10","key":"10.1016\/j.survophthal.2024.05.006_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0039-1697982","article-title":"Antiphospholipid antibody syndrome and infertility","volume":"41","author":"Rodrigues","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"10.1016\/j.survophthal.2024.05.006_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000517090","article-title":"Visual impact of early hydroxychloroquine-related retinal structural changes in patients with systemic lupus erythematosus","volume":"244","author":"Sallam","year":"2021","journal-title":"Ophthalmologica"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol."},{"issue":"8","key":"10.1016\/j.survophthal.2024.05.006_bib31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00296-018-4083-4","article-title":"Lupus retinopathy: a marker of active systemic lupus erythematosus","volume":"38","author":"Seth","year":"2018","journal-title":"Rheumatol. Int"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/0961203316660204","article-title":"Implementation of recommendations for the screening of hydroxychloroquine retinopathy: poor adherence of rheumatologists and ophthalmologists","volume":"26","author":"Shulman","year":"2017","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.semarthrit.2013.05.003","article-title":"The systemic lupus international collaborating clinics (SLICC) damage index: a systematic literature review","volume":"43","author":"Sutton","year":"2013","journal-title":"Semin Arthritis Rheumtol."},{"issue":"3","key":"10.1016\/j.survophthal.2024.05.006_bib34","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10633-017-9607-9","article-title":"Retinal toxicity related to hydroxychloroquine in patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"135","author":"Telek","year":"2017","journal-title":"Doc Ophthalmol"},{"issue":"1","key":"10.1016\/j.survophthal.2024.05.006_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000395","article-title":"Clinical impact of hydroxychloroquine dose adjustment according to the American academy of ophthalmology guidelines in systemic lupus erythematosus","volume":"7","author":"V\u00e1zquez-Otero","year":"2020","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.survophthal.2024.05.006_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8509089","article-title":"Dry eye indexes estimated by keratograph 5m of systemic lupus erythematosus patients without secondary Sj\u00f6gren's syndrome correlate with lupus activity","volume":"2019","author":"Wang","year":"2019","journal-title":"J Ophthalmol"},{"issue":"2","key":"10.1016\/j.survophthal.2024.05.006_bib37","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/jps.24663","article-title":"Chloroquine and hydroxychloroquine are novel inhibitors of human organic anion transporting polypeptide 1A2","volume":"105","author":"Xu","year":"2016","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1016\/j.survophthal.2024.05.006_bib38","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2016.298","article-title":"Hydroxychloroquine retinopathy","volume":"31","author":"Yusuf","year":"2017","journal-title":"Eye"}],"container-title":["Survey of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039625724000523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T21:17:00Z","timestamp":1725484620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039625724000523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0039625724000523"],"URL":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.006","relation":{},"ISSN":["0039-6257"],"issn-type":[{"value":"0039-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features of ocular damage in systemic lupus erythematosus and risk factors for hydroxychloroquine-related complications","name":"articletitle","label":"Article Title"},{"value":"Survey of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.survophthal.2024.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}